These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 24805127)

  • 1. Systematic review: Sprue-like enteropathy associated with olmesartan.
    Ianiro G; Bibbò S; Montalto M; Ricci R; Gasbarrini A; Cammarota G
    Aliment Pharmacol Ther; 2014 Jul; 40(1):16-23. PubMed ID: 24805127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sprue-like enteropathy linked to olmesartan.
    Campos Ruiz A; Urtasun Arlegui L; Marra-López Valenciano C
    Rev Esp Enferm Dig; 2016 May; 108(5):292-3. PubMed ID: 26925975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical, laboratory, serological, and histological profile of sprue-like enteropathy associated with olmesartan use.
    Sáez González E; Díaz Jaime FC; Del Val Antoñana A
    Rev Esp Enferm Dig; 2016 Oct; 108(10):685-686. PubMed ID: 27109007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olmesartan-Induced Enteropathy.
    Adike A; Corral J; Rybnicek D; Sussman D; Shah S; Quigley E
    Methodist Debakey Cardiovasc J; 2016; 12(4):230-232. PubMed ID: 28289500
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five cases of sprue-like enteropathy in patients treated by olmesartan.
    Théophile H; David XR; Miremont-Salamé G; Haramburu F
    Dig Liver Dis; 2014 May; 46(5):465-9. PubMed ID: 24472297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new spruelike disease as a cause of severe diarrhea].
    Halevy D; Teeuwen U; Kohlhof P
    Dtsch Med Wochenschr; 2014 Nov; 139(45):2290-3. PubMed ID: 25350242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Sprue-like enteropathy due to olmesartan: a case report].
    Agudo Fernández S
    Gastroenterol Hepatol; 2015 Feb; 38(2):108-9. PubMed ID: 24958550
    [No Abstract]   [Full Text] [Related]  

  • 8. [Olmesartan therapy and enteropathy: About two cases and review of the literature].
    Sadki A; Le Besnerais M; Héron F; Marie I
    Rev Med Interne; 2019 Feb; 40(2):112-116. PubMed ID: 30174111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olmesartan-associated sprue-like enteropathy: a systematic review with emphasis on histopathology.
    Burbure N; Lebwohl B; Arguelles-Grande C; Green PH; Bhagat G; Lagana S
    Hum Pathol; 2016 Apr; 50():127-34. PubMed ID: 26997446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Olmesartan-related sprue-like enteropathy.
    Bhat N; Anupama NK; Yelsangikar A; Vizhi K
    Indian J Gastroenterol; 2014 Nov; 33(6):564-7. PubMed ID: 25303875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olmesartan-associated sprue-like enteropathy.
    Stanich PP; Yearsley M; Meyer MM
    J Clin Gastroenterol; 2013; 47(10):894-5. PubMed ID: 23751857
    [No Abstract]   [Full Text] [Related]  

  • 12. Sprue-like enteropathy due to olmesartan.
    Muñoz-Muñoz C; López-Vivancos J; Huaman W; García-Cors M
    Rev Esp Enferm Dig; 2015 Oct; 107(10):647-8. PubMed ID: 26437988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olmesartan: sprue-like enteropathy.
    Prescrire Int; 2016 May; 25(171):130-1. PubMed ID: 27280200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An unusual cause of severe, persistent diarrhoea.
    Verstockt B; Deleenheer B; Sermon F; Van Der Steen K; Vandervoort J
    Acta Gastroenterol Belg; 2017; 80(3):416-418. PubMed ID: 29560673
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olmesartan-associated enteropathy: results of a national survey.
    Marthey L; Cadiot G; Seksik P; Pouderoux P; Lacroute J; Skinazi F; Mesnard B; Chayvialle JA; Savoye G; Druez A; Parlier D; Abitbol V; Gompel M; Eoche M; Poncin E; Bobichon R; Colardelle P; Wils P; Salloum H; Peschard S; Zerbib F; Méresse B; Cerf-Bensussan N; Malamut G; Carbonnel F
    Aliment Pharmacol Ther; 2014 Nov; 40(9):1103-9. PubMed ID: 25199794
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute renal failure secondary to diarrhea due to sprue like-enteropathy associated with olmesartan].
    Ulla-Rocha JL; Lopez-Piñeiro S; Puga-Gimenez M
    Gastroenterol Hepatol; 2015 Oct; 38(8):514-5. PubMed ID: 25534549
    [No Abstract]   [Full Text] [Related]  

  • 17. Olmesartan: sprue-like enteropathy.
    Prescrire Int; 2014 Apr; 23(148):102. PubMed ID: 24860900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sprue-like enteropathy, do not forget olmesartan!
    Melis C; Struyve M; Steelandt T; Neuville B; Deraedt K
    Dig Liver Dis; 2018 Jun; 50(6):621-624. PubMed ID: 29625908
    [No Abstract]   [Full Text] [Related]  

  • 19. An atypical case of chronic diarrhoea: olmesartan-induced sprue-like enteropathy.
    Naik DK; Martelli MG; Gonzalo DH; Sharma AK; Pannu D
    BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26370634
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic diarrhoea, weight loss and a positive anti-tissue transglutaminase antibody: A case report of olmesartan-induced enteropathy.
    Sheppard R; Evanson B; Campbell I; Shand A
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38719261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.